Attapon Cheepsattayakorn^1,2*, Ruangrong Cheepsattayakorn³ and Porntep Siriwanarangsun¹

¹Faculty of Medicine, Western University, Pathumtani Province, Thailand

*Corresponding Author: Attapon Cheepsattayakorn, 10^th Zonal Tuberculosis and Chest Disease Center, Chiang Mai, Thailand.

Received: November 07, 2022; Published: December 01, 2022

Due to immunosuppression, lung or solid-organ-transplant (SOT) patients are at increased risk of infection-related morbidity and mortality, particularly SARS-CoV-2 (COVID-19) infection [1-4]. Dramatically, COVID-19 vaccination changed both immunocompetent- and immunosuppressed-persons landscape [5]. A recent study revealed that SOT recipients with receiving a third dose of COVID-19 vaccination demonstrated improvement of humoral-immune response, compared to patients with receiving two doses [6].

References

1. Hallett AM., et al. “SARS-CoV-2 messenger RNA vaccine antibody response and reactogenicity in heart and lung transplant recipients”. The Journal of Heart and Lung Transplantation (2021).
2. L’huillier AG., et al. “Cell-mediated immune responses after influenza vaccination of solid organ transplant recipients: secondary outcomes analyses of a randomized controlled trial”. The Journal of Infectious Diseases 221 (2020): 53-62.
3. Mazzone PJ., et al. “The humoral immune response to influenza vaccination in lung transplant patients”. European Respiratory Journal 18 (2001): 971-976.
4. Scharringa S., et al. “Vaccination and their importance for lung transplant recipients in a COVID-19 world”. Expert Review of Clinical Pharmacology 14 (2021): 1413-1425.
5. Altneu E and Mishkin A. “COVID-19 vaccination in lung transplant recipients”. Indian Journal of Thoracic and Cardiovascular Surgery 2 (2022): S347-S353.
6. Efros O., et al. “Efficacy and safety of third dose of the COVID-19 vaccine among solid organ transplant recipients: a systemic review and meta-analysis”. Vaccines 10 (2022): 95.
7. Caillard S., et al. “Antibody response to a fourth messenger RNA COVID-19 vaccine dose in kidney transplant recipients: a case series”. Annals of Internal Medicine (2022).
8. Alejo JL., et al. “Antibody response to a fourth dose of a SARS-CoV-2 vaccine in solid organ transplant recipients: a case series”. Transplantation 105 (2021): e280-e281.
9. Burki TK. “Fourth dose of COVID-19 vaccines in Israel”. Lancet Respiratory Medicine (2022).

Citation

Citation: Attapon Cheepsattayakorn., et al. “Fourth Dose of COVID-19 Vaccination in Lung Transplant Recipients". Acta Scientific Microbiology 6.1 (2023): 01.

Copyright

Copyright: © 2022 Attapon Cheepsattayakorn., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.